Trial
NCT01313923
Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, Irvine
Collaborators
—
Condition
Pemphigus
Intervention
Sirolimus (formerly known as Rapamycin)
Why stopped
Lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-06-09